Transcatheter Embolization and Occlusion Devices Market Report

Transcatheter Embolization and Occlusion Devices Market Analysis Report By Product (Detachable, Pushable coils; Flow Diverting Devices, Particles, Liquid Embolics), And Segment Forecasts, 2012 - 2022

  • Published Date: Apr, 2018
  • Base Year for Estimate: 2016
  • Report ID: 978-1-68038-670-7
  • Format: Electronic (PDF)
  • Historical Data: 2012 - 2015
  • Number of Pages: 100

Industry Insights

The global transcatheter embolization and occlusion devices market size was valued at USD 2.69 billion in 2016 and is expected to grow at a CAGR of 10.13% over the forecast period. The market is witnessing tremendous growth over the last decade. The paradigm shifts from clipping to coiling has stimulated the demand for transcatheter embolization devices.

Japan embolization coils market

On the other hand, costly products, stringent regulatory approval procedures, and requirement of skilled professionals to perform the procedures are some of the factors impeding growth at global level. Considering all the above-mentioned factors, global TEO devices market is anticipated to reach USD 4.8 billion in 2022 growing at a CAGR of 10.2% from 2015 to 2022.

Increasing adoption of this technique is also seen while using Transcatheter Embolization and Occlusion (TEO) devices. Noncoil products such as embolization particles and liquid embolics support minimally invasive surgery. Thus, use of these devices helps avoid complications such as imprecise deployment, catheter entrapment, and balloon deflation associated with coiling. Therefore, surgeons are increasingly shifting toward noncoil devices to leverage on the benefits associated with it, which thereby drives the demand for TEO devices in the market.

Furthermore, various government initiatives to improve healthcare infrastructure and manufacturing industry of the respective country are attracting global players to this region. For example, healthcare spending by the Government of China was USD 590.2 billion, i.e., 5.7% of GDP in 2014. Considering rising healthcare spending coupled with the rapidly growing medical tourism industry, demand for TEO devices in Asia-Pacific is expected to grow swiftly.

Therapy Insights

Non-coils devices segment includes coiling assist devices, flow diverting devices, embolization particles, liquid embolics, other embolization and occlusion devices, and accessories. Rising demand for minimally invasive surgeries is one of the prime factors pushing the noncoil devices segment toward growth. As a result, noncoil devices segment is anticipated to grow at the fastest growth rate during the forecast period.

Global embolization coils market

Presently, accessories segment accounted for the largest revenue share among other products available in the market. Inclusion of various accessories used along with a wide variety of commercially available embolization products resulted in it becoming the largest revenue-generating segment in 2016. However, demand for embolization particles is expected to grow swiftly as they support minimally invasive surgeries. Thus, embolization particles market is expected to grow at the fastest growth rate during the forecast period.

Regional Insights

North America and Europe together accounted for the majority revenue share in 2014. The presence of well-defined regulatory framework, advanced healthcare infrastructure, and experienced healthcare professionals to perform the procedures are some of the factors observed to fuel demand for TEO in these regions.

Furthermore, North America and Europe are anticipated to maintain their dominance throughout the forecast period. Higher spending capacity and presence of large population pool suffering from cancer coupled with higher adoption rate for advanced healthcare technology are expected to boost the growth in North America and Europe.

Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. The booming medical tourism industry in emerging economies such as India, China, and Malaysia is attracting global cancer patients. As a result, demand for TEO treatments in these countries is expected to rise swiftly.

Transcatheter Embolization & Occlusion Devices Market Share Insights

Some of the key players of the transcatheter embolization and occlusion devices market include Terumo Corporation; Medtronic, Inc.; Boston Scientific Corporation; Stryker Corporation; Cordis Corporation; DePuy Synthes; St. Jude Medical; Cook Medical; Sirtex medical; and Nordian.

Market players are trying to expand their revenue share through various strategies such as acquisition of small players which expands their product offering and  geographic reach. Similarly, long term contracts with the hospitals and surgeons to ensure the sales is one such strategy adopted by the market players to maximize their profit margins

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2012 - 2015

Forecast period

2017- 2022

Market representation                                                 

Revenue in USD Million and CAGR from 2015 to 2022

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Country scope

U.S., Canada, U.K., Germany, Japan, China, Brazil, Mexico, South Africa.

Report coverage             

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub-segments from 2012 - 2022. For the purpose of this study, Grand View Research has segmented the global transcatheter embolization and occlusion devices market report on the basis of product type, and region:

  • Product Type Outlook (Revenue, USD Million, 2012 - 2022)

    • Coil

      • Pushable Coils

      • Detachable Coils

    • Non Coil

      • Flow Diverting Devices

      • Embolization Particles

      • Liquid Embolics

      • Other Embolization and Occlusion Devices

      • Accessories

  • Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,450
Multi User (2-5) - $6,450
BI Library Access - $8,450

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified